Portage Biotech to Participate in Panel Discussion During the 2023 BIO International Conference
WESTPORT, Conn., June 01, 2023 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company advancing novel multi-targeted therapies for use as single agents and in combination, announced today that CEO Dr. Ian Walters will serve as an expert spokesperson on an oncology panel discussion at the upcoming BIO International Conference taking place in Boston, Massachusetts June 5-8, 2023.
Panel Date and Time: Thursday, June 8, 10:15 – 11:15 a.m. ET Session Room 254A
Dr. Walters will be joined by industry experts during the panel to explore the future of the immune checkpoint inhibitor (ICI) space and the up-and-coming approaches to reactivating the body's own immune system. The panelists will discuss how the field of immuno-oncology has evolved, strategies to improve success in ICIs and entirely new approaches.
In additio to the panel, members of Portage’s management team will be in attendance to explore potential collaborations and partnerships with other industry leaders.
For more information on the panel and to register, visit the website.
About Portage Biotech Inc.
FOR MORE INFORMATION, PLEASE CONTACT:
Keynote Presentation by Genesys
ITEXPO #TECHSUPERSHOW Expo Hall Grand Opening